Anne Szarewski - Concepedia

Author

Anne Szarewski

Queen Mary University of London

Also Known As

*Anne Szarewski, A Szarewski, A. Szarewski, ANNE SZAREWSKI, Anne Szarewski, Suzanne M Garland, Szarewski, Szarewski, A

175

Publications

10.1K

Citations

H-Index

Concepts

All Affiliations

Queen Mary University of London Cancer Research UK University College London The University of Sydney Institut Català d'Oncologia

About

Anne Szarewski is an author at Queen Mary University of London specializing in medicine, public health, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	18	4.4K
2	Public Health	14	17	4.4K
3	Social Sciences	2	2	32
4	Engineering	1	1	34
5	Biostatistics	1	1	14

Anne Szarewski

Publications

8.1K

Citations

H-Index

Page 1

	Year	Citations
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women Jorma Paavonen, Paulo Naud, Jorge Salmerón, The Lancet As04-adjuvanted VaccineGynecologyOncogenic Hpv TypesCancer-associated VirusCervical Cancer Prevention	2009	1.6K
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial Matti Lehtinen, Jorma Paavonen, Cosette M. Wheeler, The Lancet Oncology VaccinationCervical Cancer ScreeningHpv-16/18 As04-adjuvanted VaccineCervical CancerCervical Health	2011	693
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study Joakim Dillner, Matejka Rebolj, Philippe Birembaut, BMJ	2008	627
Management of women who test positive for high-risk types of human papillomavirus: the HART study Jack Cuzick, Anne Szarewski, Heather Cubie, The Lancet Cancer DetectionHuman Papillomavirus VaccinesCancer ScreeningHart StudyDiagnostic Test	2003	502
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial Cosette M. Wheeler, Xavier Castellsagué, Suzanne M. Garland, The Lancet Oncology VaccinationVaccine SafetyCervical Cancer ScreeningPreventive MedicineCervical Cancer	2011	499
Human papillomavirus testing in primary cervical screening Jack Cuzick, Anne Szarewski, George Terry, The Lancet Primary Cervical ScreeningCervical Cancer ScreeningCervical Cancer ManagementCervical CancerCervical Health	1995	330
Comparison of Predictors for High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears Anne Szarewski, Laurence Ambroisine, Louise Cadman, Cancer Epidemiology Biomarkers & Prevention	2008	229
Comparing the performance of six human papillomavirus tests in a screening population Jack Cuzick, Louise Cadman, David Mesher, British Journal of Cancer	2013	209
Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study Unnop Jaisamrarn, Xavier Castellsagué, Suzanne M. Garland, PLoS ONE	2013	206
Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact Kirsten McCaffery, Jo Waller, Sue Forrest, BJOG An International Journal of Obstetrics & Gynaecology	2004	202

Page 1